Squarepoint Ops LLC Makes New $1.28 Million Investment in LifeStance Health Group, Inc. $LFST

Key Points

• Squarepoint Ops LLC acquired 119,763 LifeStance Health Group shares worth approximately $1.28 million in the second quarter. Institutional investors collectively own 85.5% of LFST, with several major firms also increasing or initiating positions.
• LifeStance reported quarterly revenue of $435.35 million, up 26.1% year over year, and earnings of $0.06 per share—beating analysts’ $0.03 estimate. Analysts expect approximately $0.16 in full-year EPS.
• Insiders sold significant holdings, including TPG’s sale of 13.6 million shares and the COO’s sale of 47,912 shares; insiders sold roughly $155.5 million of stock over the past 90 days. Analysts maintain a “Moderate Buy” consensus with an average price target of $12.88.

Squarepoint Ops LLC bought a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 119,763 shares of the company's stock, valued at approximately $1,283,000.

A number of other large investors have also modified their holdings of LFST. BlackRock Inc. purchased a new stake in shares of LifeStance Health Group during the 2nd quarter valued at about $389,293,000. Silversmith Partners I GP LLC acquired a new position in shares of LifeStance Health Group during the fourth quarter worth $100,842,000. Dimensional Fund Advisors LP lifted its position in shares of LifeStance Health Group by 16.4% during the first quarter. Dimensional Fund Advisors LP now owns 10,367,680 shares of the company's stock worth $66,038,000 after purchasing an additional 1,461,215 shares in the last quarter. Jennison Associates LLC boosted its stake in shares of LifeStance Health Group by 38.5% in the first quarter. Jennison Associates LLC now owns 10,228,801 shares of the company's stock valued at $65,157,000 after purchasing an additional 2,843,388 shares during the period. Finally, Wellington Management Group LLP acquired a new stake in LifeStance Health Group during the 2nd quarter valued at $30,881,000. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Stock Down 2.1%

Shares of NASDAQ:LFST opened at $12.79 on Thursday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The company has a fifty day simple moving average of $11.81 and a 200 day simple moving average of $9.14. The firm has a market cap of $4.89 billion, a PE ratio of 98.39 and a beta of 1.22. LifeStance Health Group, Inc. has a 12-month low of $4.77 and a 12-month high of $13.56.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The firm had revenue of $435.35 million for the quarter, compared to analysts' expectations of $414.58 million. During the same period in the prior year, the company posted ($0.01) earnings per share. The firm's quarterly revenue was up 26.1% on a year-over-year basis. On average, equities research analysts anticipate that LifeStance Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Insider Activity at LifeStance Health Group

In other news, COO Lisa Miller sold 47,912 shares of the company's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the sale, the chief operating officer owned 281,289 shares in the company, valued at approximately $3,051,985.65. This represents a 14.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.62, for a total transaction of $144,890,858.34. Following the transaction, the insider directly owned 98,101,407 shares in the company, valued at $1,041,836,942.34. The trade was a 12.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 14,671,917 shares of company stock worth $155,493,415. Company insiders own 3.50% of the company's stock.

Wall Street Analysts Forecast Growth

LFST has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a "neutral" rating in a report on Friday, August 14th. The Goldman Sachs Group initiated coverage on LifeStance Health Group in a research note on Friday, June 5th. They set a "neutral" rating and a $9.00 target price for the company. Canaccord Genuity Group lifted their target price on LifeStance Health Group from $13.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, September 9th. KeyCorp boosted their price target on LifeStance Health Group from $11.00 to $13.00 and gave the stock an "overweight" rating in a research note on Monday, July 13th. Finally, Weiss Ratings raised LifeStance Health Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, LifeStance Health Group has a consensus rating of "Moderate Buy" and a consensus price target of $12.88.

LifeStance Health Group Profile

LifeStance Health Group, Inc is a behavioral health care company that provides outpatient mental health services through in-person and virtual appointments. Its platform connects patients with psychiatrists, psychologists, psychiatric nurse practitioners, therapists and other licensed clinicians.

The company offers services that may include psychotherapy, psychiatric evaluations, medication management and treatment for conditions such as anxiety, depression, attention-deficit/hyperactivity disorder and other behavioral health needs.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.